[CLDX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
08-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -143.78%
YoY- -293.09%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 967 1,613 407 163 174 333 153 242.22%
PBT -29,361 -26,487 -26,784 -36,004 -23,050 -20,148 -20,679 26.35%
Tax -6,946 -2,796 -912 16,564 -1,486 -874 -227 880.34%
NP -22,415 -23,691 -26,784 -52,568 -21,564 -20,148 -20,452 6.30%
Tax Rate - - - - - - - -
Total Cost 23,382 25,304 27,191 52,731 21,738 20,481 20,605 8.80%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -2,317.99 -1,468.75 -6,580.84 -32,250.31 -12,393.10 -6,050.45 -13,367.32 -68.93%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.47 -0.50 -0.57 -1.12 -0.46 -0.43 -0.45 2.94%
EPS Diluted -0.47 -0.50 -0.57 -1.12 -0.46 -0.43 -0.45 2.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.